S

Septerna

Licenses GPCR discovery platform to pharma

Associate Director of Process Chemistry

Bioprocess & BiomanufacturingConfirmed live in the last 24 hours
Full-timeSouth San Francisco, CA, USAIn-person

About the Job

Requirements

  • A PhD, MS, or BS degree in organic chemistry or a related field, with at least 7, 10, or 12 years, respectively, of relevant industry experience in small molecule drug substance development and increasing responsibilities within process chemistry.
  • A track record of successfully delivering drug substance activities from non-GLP and IND-enabling material supplies through GMP clinical trial supplies and commercialization.
  • Expertise in small molecule synthetic route evaluation, process development, scale-up, manufacturing, and phase-appropriate control strategy and specification development.
  • Experience with analytical techniques supporting small molecule process development, including proficiency in UPLC/HPLC, GC, MS, NMR, and solid-state characterization techniques such as particle size distribution and XRPD.
  • Strong understanding of Quality systems, including SOPs, manufacturing record review, batch release and disposition, Good Documentation Practices, cGMP data traceability, deviations, and change management.
  • Knowledge and application of current industry and compendial standards and regulatory authority guidance and expectations, including ICH, FDA, MHRA, and EMA guidelines and USP-NF, Ph. Eur, BP, and JP compendia.
  • Ability to manage and collaborate with external partners, including consultants and CDMOs.
  • Ability to prepare high-quality technical documentation and present data to peers, management, and external groups.
  • Ability to travel domestically and internationally as needed, up to 20% of the time.

Responsibilities

  • Act as a Process Chemistry subject matter expert supporting drug substance development, including process chemistry, solid form selection, crystallization development, and GMP manufacture.
  • Lead process development efforts, including route scouting, process optimization, and scale-up, and implement mitigation strategies to ensure robust, cost-effective, safe, scalable, and phase-appropriate manufacturing processes.
  • Contribute to CMC control strategies defining starting materials, impurity control strategies, and specifications for starting materials, intermediates, and drug substance in alignment with industry standards and regulatory expectations.
  • Support the evaluation, selection, technology transfer, and management of CDMOs for route and process development and GMP manufacture.
  • Contribute to CMC strategies that meet program and project development targets, ensure timely delivery of high-quality products, and facilitate regulatory approvals.
  • Collaborate within CMC with Analytical Chemistry and Formulation Development, and across Quality, Medicinal Chemistry, DMPK, Toxicology, Project Management, Development Sciences, and Clinical Pharmacology to achieve project goals.
  • Manage multiple priorities and solve problems to ensure on-time drug supply for non-GLP toxicology studies, IND-enabling activities, and clinical trials across multiple programs.
  • Support development of the Quality system to ensure product quality and data integrity, including authoring and reviewing standard operating procedures, guidelines, and work instructions.
  • Author and review process development reports, batch records, campaign reports, change controls, corrective and preventative actions, deviations, and investigations.
  • Write and review CMC sections of regulatory documents and submissions (IMPD, IB, IND, NDA, etc.) and supporting technical documents, and remain current on Health Authority guidance and expectations.

About the Company

Septerna

Licenses GPCR discovery platform to pharma

Septerna develops and licenses a platform called Native Complex™ that enables drug discovery on G protein-coupled receptors (GPCRs) outside of cells. The platform reproduces GPCRs with their original structure, function, and dynamics, allowing scientists to design drugs based on GPCR structures and to perform ultra-large-scale screening across the full GPCR target class. This helps unlock GPCR targets that were previously hard to study and could lead to new medicines. The company differentiates itself by offering an industrial-scale, structure-based discovery workflow specifically for GPCRs, paired with a licensing business model for pharmaceutical companies. Its goal is to expand therapeutic options by turning more GPCRs—previously considered undruggable—into viable drug targets and to bring GPCR-targeted medicines to market through licensing and partnerships.

Company size
51-200
Company stage
IPO
Headquarters
South San Francisco, CA
Founded
2022

Recently Posted Jobs

Explore more opportunities at Septerna

See more jobs